In May of 2018 Kite Pharma, a Gilead Company, announced the opening of a new Neo Antigen Facility in Gaithersburg, MD. Less than one year later in April of 2019, the company, announced that it was building a new biomanufacturing facility on a 20-acre site in Frederick, MD. Since then, Kite has been diligently working to build a world-class leadership team at both sites to achieve an important mission.
Image: https://biobuzz.io
{iframe}https://biobuzz.io/kite-hosts-marylands-cell-therapy-and-biomanufacturing-community-to-share-their-mission-to-cure-cancer/{/iframe}